Home
/
INSMED Inc
/
Financials
/
Quarterly
INSMED Inc — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that INSMED Inc filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Sep 30, 2018
$0
Oct 30, 2018
Q2
2018
Jun 30, 2018
$0
Aug 2, 2018
Q1
2018
Mar 31, 2018
$0
May 2, 2018
Q3
2018
Sep 30, 2017
$0
Oct 30, 2018
Q2
2018
Jun 30, 2017
$0
Aug 2, 2018
Q1
2018
Mar 31, 2017
$0
May 2, 2018
Q3
2017
Sep 30, 2016
$0
Nov 2, 2017
Q3
2013
Sep 30, 2013
$11.50M
Nov 5, 2013
Q2
2013
Jun 30, 2013
$11.50M
Aug 6, 2013
Q3
2012
Sep 30, 2012
$0
Nov 7, 2012
Q2
2012
Jun 30, 2012
$0
Aug 7, 2012
Q1
2012
Mar 31, 2012
$0
May 8, 2012
Q3
2012
Sep 30, 2011
$435.0K
Nov 7, 2012
Q2
2012
Jun 30, 2011
$978.0K
Aug 7, 2012
Q1
2012
Mar 31, 2011
$1.60M
May 8, 2012
Q3
2011
Sep 30, 2010
$1.81M
Nov 9, 2011
Q2
2011
Jun 30, 2010
$1.86M
Aug 8, 2011
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$142.34M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$107.42M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$92.82M
May 8, 2025
Q3
2025
Sep 30, 2024
$93.43M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$90.34M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$75.50M
May 8, 2025
Q3
2024
Sep 30, 2023
$79.07M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$77.23M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$65.21M
May 9, 2024
Q3
2023
Sep 30, 2022
$67.73M
Oct 26, 2023
Q2
2023
Jun 30, 2022
$65.22M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$53.11M
May 4, 2023
Q3
2022
Sep 30, 2021
$46.76M
Oct 27, 2022
Q2
2022
Jun 30, 2021
$45.37M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$40.21M
May 5, 2022
Q3
2021
Sep 30, 2020
$43.64M
Oct 28, 2021
Q2
2021
Jun 30, 2020
$42.50M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$36.86M
May 6, 2021
Q3
2020
Sep 30, 2019
$38.89M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$29.97M
Aug 6, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($370.02M)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($321.69M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($256.58M)
May 8, 2025
Q3
2025
Sep 30, 2024
($220.52M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($300.61M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($157.09M)
May 8, 2025
Q3
2024
Sep 30, 2023
($158.93M)
Oct 31, 2024
Q2
2024
Jun 30, 2023
($244.81M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($159.76M)
May 9, 2024
Q3
2023
Sep 30, 2022
($131.15M)
Oct 26, 2023
Q2
2023
Jun 30, 2022
($95.65M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($94.62M)
May 4, 2023
Q3
2022
Sep 30, 2021
($112.71M)
Oct 27, 2022
Q2
2022
Jun 30, 2021
($117.32M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($91.64M)
May 5, 2022
Q3
2021
Sep 30, 2020
($63.66M)
Oct 28, 2021
Q2
2021
Jun 30, 2020
($61.85M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($66.36M)
May 6, 2021
Q3
2020
Sep 30, 2019
($60.68M)
Oct 29, 2020
Q2
2020
Jun 30, 2019
($66.51M)
Aug 6, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($366.01M)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($312.88M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($248.14M)
May 8, 2025
Q3
2025
Sep 30, 2024
($213.43M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($288.90M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($145.51M)
May 8, 2025
Q3
2024
Sep 30, 2023
($147.67M)
Oct 31, 2024
Q2
2024
Jun 30, 2023
($235.53M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($148.16M)
May 9, 2024
Q3
2023
Sep 30, 2022
($127.70M)
Oct 26, 2023
Q2
2023
Jun 30, 2022
($88.32M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($89.83M)
May 4, 2023
Q3
2022
Sep 30, 2021
($103.62M)
Oct 27, 2022
Q2
2022
Jun 30, 2021
($88.57M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($83.83M)
May 5, 2022
Q3
2021
Sep 30, 2020
($56.22M)
Oct 28, 2021
Q2
2021
Jun 30, 2020
($54.11M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($60.36M)
May 6, 2021
Q3
2020
Sep 30, 2019
($56.49M)
Oct 29, 2020
Q2
2020
Jun 30, 2019
($62.17M)
Aug 6, 2020